Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. - Wikidata - wikimedia - TriplyDB

Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.

Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.

http://www.wikidata.org/entity/Q34835012

about

Deletion of PPARgamma in adipose tissues of mice protects against high fat diet-induced obesity and insulin resistance Is the Mouse a Good Model of Human PPARγ-Related Metabolic Diseases?Role of Transcription Factors in Steatohepatitis and Hypertension after Ethanol: The Epicenter of Metabolism Hydroxycinnamic acid derivatives: a potential class of natural compounds for the management of lipid metabolism and obesity Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases Orphan nuclear receptors and the regulation of nutrient metabolism: understanding obesity Energy metabolism in the liver Commonalities in the Association between PPARG and Vitamin D Related with Obesity and Carcinogenesis 'Striking the Right Balance' in Targeting PPARgamma in the Metabolic Syndrome: Novel Insights from Human Genetic Studies Glial cell line-derived neurotrophic factor protects against high-fat diet-induced hepatic steatosis by suppressing hepatic PPAR-γ expression Regressive Effect of Myricetin on Hepatic Steatosis in Mice Fed a High-Fat Diet Severe Atherosclerosis and Hypercholesterolemia in Mice Lacking Both the Melanocortin Type 4 Receptor and Low Density Lipoprotein Receptor Changes in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob mice PAS kinase is required for normal cellular energy balance Molecular mediators of hepatic steatosis and liver injury PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD.PPAR gamma 2 prevents lipotoxicity by controlling adipose tissue expandability and peripheral lipid metabolism.All-trans-retinoic acid ameliorates hepatic steatosis in mice by a novel transcriptional cascade.Regulation of steatohepatitis and PPARγ signaling by distinct AP-1 dimers.Dynamic and differential regulation of proteins that coat lipid droplets in fatty liver dystrophic mice.Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice.Effects of the PPARgamma agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus.C-C chemokine receptor 2 (CCR2) regulates the hepatic recruitment of myeloid cells that promote obesity-induced hepatic steatosis.Immune and Metabolic Regulation Mechanism of Dangguiliuhuang Decoction against Insulin Resistance and Hepatic Steatosis.Prosteatotic genes are associated with unsaturated fat suppression of saturated fat-induced hepatic steatosis in C57BL/6 mice.Early hepatic insulin resistance precedes the onset of diabetes in obese C57BLKS-db/db mice.CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice.Hsp90 modulates PPARγ activity in a mouse model of nonalcoholic fatty liver disease.Sex dimorphic actions of rosiglitazone in generalised peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-deficient mice PPARs, Obesity, and Inflammation Involvement of inducible 6-phosphofructo-2-kinase in the anti-diabetic effect of peroxisome proliferator-activated receptor gamma activation in mice.Peroxisome proliferator-activated receptor-gamma: too much of a good thing causes harm Gene Expression Changes Induced by PPAR Gamma Agonists in Animal and Human Liver.Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas.Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges.Supplementation of persimmon leaf ameliorates hyperglycemia, dyslipidemia and hepatic fat accumulation in type 2 diabetic mice.Lipid metabolism and liver inflammation. II. Fatty liver disease and fatty acid oxidation.Emerging roles of the myocardin family of proteins in lipid and glucose metabolism.Ghrelin promotes hepatic lipogenesis by activation of mTOR-PPARγ signaling pathway.Protopanaxatriol, a novel PPARγ antagonist from Panax ginseng, alleviates steatosis in mice.

P2860

Q24555727-E59602A5-7613-491F-8898-034069D8729E Q26739984-70B0BB97-7EBF-4404-B84A-251341AE0C44 Q26746981-57DA370C-74C7-4718-8199-DC4DBF1F76A9 Q26749072-7511C6E5-9B66-44EB-85D2-A687B15BDFD1 Q26778328-431529BA-4ED6-4FB5-9F98-5845FBF185A9 Q26823819-4F78E9D7-4D01-4BFF-A91E-1DD6DB0C38C5 Q26996783-F2D6DB53-BDF1-4547-B080-42223C49F726 Q28070220-D5ACEC2C-4A9E-4DDF-85BE-09CF0611800C Q28221639-417B1B4E-C04E-443E-A114-ACEAD8CFFBE8 Q28354027-49D70085-39A4-4AF7-986C-7F71A4053710 Q28354293-B31870DE-6B9D-4A2A-8A31-4072F35C8465 Q28468525-2A77F5F9-02D3-4317-9F56-216D840FAD98 Q28476015-D0D6595A-8189-42A0-B3A6-EBF823ACE983 Q28506039-684F5E31-55DB-4893-A6A5-2093E8EF4960 Q29616709-77383897-9D71-46E1-A23C-EB819494395D Q30241952-07F82C80-2E1F-4945-9DDA-B24DCAA558A4 Q33283063-EA86A77B-B641-4FE9-B671-0C0123302D05 Q33558905-3DBC32D7-1159-4E8D-9D47-DA796AB29D25 Q33621757-C23D7177-073B-408B-ACA0-F069D1A08FC8 Q33634147-2A8BB319-421B-4E7C-A288-297386F48614 Q33717836-23BA1934-DE67-487E-965D-3E39364113F5 Q33727061-13646196-697A-40DB-B126-63D81FA6F5EE Q33750735-1AC80882-BB70-4179-B70C-853BA9FBB557 Q33881724-A0D31E20-9DF5-4A58-AEB4-44E26CD699D0 Q33922486-9E69D0A4-13BA-48A1-89BF-47207BC6F7F0 Q33930211-7D91F5AD-0C8B-4305-BCF8-25B080FE8DBE Q33943164-0C071D62-B1B6-4F9F-A642-82FDC27DC1C2 Q33945101-998141B1-C4D4-4250-BBCB-11BB562B1BD3 Q33957864-D20983E8-CA51-4344-9026-BBD6217872C8 Q34003196-93D8AF1E-EA5E-434A-857F-0204CF656EFB Q34025180-834621CF-7710-4B92-99CF-71D94F1071E1 Q34165847-7C32A15E-2DDA-4071-80B5-E9D7304C3241 Q34235817-557EE7D8-C145-40C4-960B-CDB29984EFC5 Q34380511-B15EBE13-4A7E-40E1-BD83-C35685B606D8 Q34451866-3FD9E4BD-E380-4B13-B5A8-CEAD2591D2C4 Q34473894-0B13FA38-CE92-46D3-9DF3-192C0CD68CF7 Q34512108-CA61E7CA-9D4D-4D2A-8340-AD8152BCC408 Q34521411-0FD7B68E-C485-476F-8C9A-4D287DF03C63 Q34583651-1B56F79D-203D-45B9-B811-3260A1D9359E Q34659350-49745EE5-DCF7-4ECF-901A-8B2283688E51

P2860

Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes.

http://www.wikidata.org/entity/Q34835012

description

2003 nî lūn-bûn

@nan

2003 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մարտին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Liver-specific disruption of P ...... ggravates diabetic phenotypes.

@ast

Liver-specific disruption of P ...... ggravates diabetic phenotypes.

@en

Liver-specific disruption of P ...... ggravates diabetic phenotypes.

@nl

type

label

Liver-specific disruption of P ...... ggravates diabetic phenotypes.

@ast

Liver-specific disruption of P ...... ggravates diabetic phenotypes.

@en

Liver-specific disruption of P ...... ggravates diabetic phenotypes.

@nl

prefLabel

Liver-specific disruption of P ...... ggravates diabetic phenotypes.

@ast

Liver-specific disruption of P ...... ggravates diabetic phenotypes.

@en

Liver-specific disruption of P ...... ggravates diabetic phenotypes.

@nl

P1433

Q34835012-E5FB51B2-05B9-461B-AFB7-6E8D8E038DE3

P1476

Q34835012-6EA18C1A-F047-4D5F-88A7-08900E1AF555

P2093

Q34835012-1BEA0DD0-3367-45BC-A487-D39341D5B534

Q34835012-3EB8087D-DC32-4AB0-9D06-90F68EA805C4

Q34835012-79B0640E-9D43-44E8-BB41-52F4614DA8CE

Q34835012-8EE8C513-BBC6-4C7B-8F5C-9498438FE246

Q34835012-934F1AF0-DFE0-45DD-BFD1-7C2E566B10CA

Q34835012-B15917D3-0103-4637-BE0A-643C67B84C00

Q34835012-CA6AF74B-1CCB-4A4A-AB24-52EC8B0FEF52

Q34835012-DCE0E408-B732-4654-9A73-18A69056F95A

Q34835012-E67D7853-041E-41D1-B1B6-9BB51F8B3676

P2860

Q34835012-020921EC-63B5-4BE0-B8D5-40677B59B81D

Q34835012-03AB6192-67AE-4446-B2C3-AC3EEAD81120

Q34835012-044D9ED8-8DAB-408A-B06A-15BEBBE2E12C

Q34835012-0C7D5019-1099-4354-A24F-3958CF963C35

Q34835012-0D448910-0F2D-4E41-B55F-86C35DF99696

Q34835012-0D49EEF8-ED35-41E7-A9C9-4C13922C84CA

Q34835012-17640364-884F-446A-9F74-86A4EE17B642

Q34835012-1BD83C32-5767-43A0-9F17-7E669F6C7DC0

Q34835012-1D425C62-1552-4E84-A776-3173F7503035

Q34835012-2AB15EDE-2422-4C28-ABCB-EABF168D5D00

P304

Q34835012-EB5A894E-5441-4B59-9FE4-B9638E83334B

P31

Q34835012-07B0EC66-CCD3-4561-BAF1-509434D33DBD

P356

Q34835012-E782ED4F-129B-4187-BE44-DE70D2D45466

P407

Q34835012-2C83FC7A-FC0A-447A-A540-0D6ABEF07F39

P433

Q34835012-98642534-03F9-493B-A704-E04A67CAE4EC

P478

Q34835012-0C18E3A9-AA0F-4D5B-B36C-10F7CB36554C

P577

Q34835012-ED728000-FF5B-4692-8E70-54E29E794CE2

P698

Q34835012-80A48D6D-15E7-4067-9C9D-AF14D03894F6

P932

Q34835012-10DAFC88-271F-4065-B782-23E19E955C82

P356

P1433

Journal of Clinical Investigation

P1476

Liver-specific disruption of P ...... ggravates diabetic phenotypes.

@en

P2093

Bryan Brewer

http://www.w3.org/2001/XMLSchema#string

Frank J Gonzalez

http://www.w3.org/2001/XMLSchema#string

Gilles Lambert

http://www.w3.org/2001/XMLSchema#string

Jerrold M Ward

http://www.w3.org/2001/XMLSchema#string

Kimihiko Matsusue

http://www.w3.org/2001/XMLSchema#string

Marc L Reitman

http://www.w3.org/2001/XMLSchema#string

Martin Haluzik

http://www.w3.org/2001/XMLSchema#string

Oksana Gavrilova

http://www.w3.org/2001/XMLSchema#string

Sun-Hee Yim

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of liver X receptor-retinoid X receptor as an activator of the sterol regulatory element-binding protein 1c gene promoter

Defective fatty acid uptake modulates insulin responsiveness and metabolic responses to diet in CD36-null mice

Mechanism of free fatty acid-induced insulin resistance in humans

Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRalpha and LXRbeta

A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION

PPAR gamma is required for the differentiation of adipose tissue in vivo and in vitro

A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis

Hepatic lipase: a pro- or anti-atherogenic protein?

The organization, promoter analysis, and expression of the human PPARgamma gene

ABCA1 overexpression leads to hyperalphalipoproteinemia and increased biliary cholesterol excretion in transgenic mice

P304

737-747

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI200317223

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2003-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12618528

http://www.w3.org/2001/XMLSchema#string

P932

151902

http://www.w3.org/2001/XMLSchema#string